Androstenedione is the preferred androgen source in hormone refractory prostate cancer--response.

Christopher M Hovens,Matthew K H Hong,Niall M Corcoran

CLINICAL CANCER RESEARCH（2014）

引用 1|浏览1

暂无评分

摘要

We would like to thank Drs. Sharifi and Auchus for their interest in our study, and appreciate the opportunity to address the issues they have raised ([1][1]). Their main point of contention concerns our ability to make informed comment on the contribution of the “5α-dione” pathway to DHT

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要